Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
563-03-005 ISMRM Abstract

Optimized Time-Dependent Diffusion MRI for Preoperative Molecular Subtyping of Adult Diffuse Gliomas

Primary: Neuro - Tumors
Secondary: Diffusion - Microstructure
563-03-005 · Image Classification for Brain Cancer · Wednesday, 13 May, 1:40 PM–2:35 PM · Digital Posters Row D
Keywords: Time-dependent diffusion MRI Adult-type diffuse glioma IMPULSED OGSE diffusion imaging Molecular subtyping
Accepted
Xin Ge 1,2, Yuhui Xiong3, Jing Zhang4, Wen Wang1,2
1Department of Radiology & Functional and Molecular Imaging Key Lab of Shaanxi Province, Tangdu Hospital, Fourth Military Medical University, Xi'an, China
27T MRI Precision Neurology Platform of Shaanxi Province, Tangdu Hospital, Fourth Military Medical University, Xi'an, China
3GE HealthCare MR Research, Beijing, China
4The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
Presenting Author: Xin Ge

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Jiang T, Nam DH, Ram Z, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2021,499:60-72. doi:10.1016/j.canlet.2020.10.050. [doi]
2. Louis D N, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncology. 2021,23(8):1231-1251.doi:10.1093/neuonc/noab106 [doi]
3. Mellinghoff IK, van den Bent MJ, Blumenthal DT, et al. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma. N Engl J Med. 2023;389(7):589-601. doi:10.1056/NEJMoa2304194. [doi]
4. Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013;31(3):337-343.
5. Hannum AJ, Cork TE, Setsompop K, Ennis DB. Phase stabilization with motion compensated diffusion weighted imaging. Magn Reson Med. 2024;92(6):2312-2327. doi:10.1002/mrm.30218. [doi]
6. Jiang X, Li H, Xie J, Zhao P, Gore JC, Xu J. Quantification of cell size using temporal diffusion spectroscopy. Magn Reson Med. 2016;75(3):1076-1085. doi:10.1002/mrm.25684. [doi]
7. Xu J. Probing neural tissues at small scales: Recent progress of oscillating gradient spin echo (OGSE) neuroimaging in humans. J Neurosci Methods. 2021;349:109024. doi:10.1016/j.jneumeth.2020.109024. [doi]
8. Wu D, Jiang K, Li H, et al. Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer. Radiology. 2022;303(3):578-587. doi:10.1148/radiol.211180. [doi]
9. Kamimura K, Tokuda T, Kamizono J, et al. Time-dependent MR diffusion analysis of functioning and nonfunctioning pituitary adenomas/pituitary neuroendocrine tumors. J Neuroimaging. 2025;35(1):e13254. doi:10.1111/jon.13254. [doi]
10. Su Y, Qiu Y, Huang X, et al. Benign and Malignant Breast Lesions: Differentiation Using Microstructural Metrics Derived from Time-Dependent Diffusion MRI. Radiol Imaging Cancer. 2025;7(3):e240287. doi:10.1148/rycan.240287. [doi]
11. Zhu A, Shih R, Huang RY, et al. Revealing tumor microstructure with oscillating diffusion encoding MRI in pre-surgical and post-treatment glioma patients. Magn Reson Med. 2023;90(5):1789-1801.doi:10.1002/mrm.29758. [doi]
12. Zhu A, Michael ES, Li H, et al. Engineering clinical translation of OGSE diffusion MRI. Magn Reson Med. 2025;94(3):913-936.doi:10.1002/mrm.30510. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/563-03-005